Research Article
Novel Poly(L-lactide-co-ε-caprolactone) Matrices Obtained with the Use of Zr[Acac]4 as Nontoxic Initiator for Long-Term Release of Immunosuppressive Drugs
Table 1
Characterization of poly(L-lactide-co-ε-caprolactone) matrices containing cyclosporine A or rapamycine (: number-average molar mass; : molar-mass dispersity; : glass transition temperature, : melting temperature; , : the average length of lactidyl and caproyl blocks; : randomization ratio; : initiator to monomer molar ratio).
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Obtained by DCS (second heating); bobtained by DSC (first heating). |